Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Right-heart response to short-term low oxygen in people with past HAPE

Official title: Effect of Acute Hypoxia on RIght VEntRicular Function. A Single-Center, Double-Blind, Randomized Controlled Cross-Over Trial.

Run by University of Zurich · NCT07431554 · Data updated 2026-11-12

This trial tests whether brief exposure to simulated high altitude (low oxygen) changes right-heart function in adults who previously had high-altitude pulmonary edema (HAPE).

More Hypoxia trials

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment18 (estimated)
SponsorUniversity of Zurich
Academic / other
Locations1 site (Zurich)
StatusRecruiting
StartedMarch 17, 2026
Main results expectedJanuary 2030
Study endsJanuary 2030
Registry record updatedMay 1, 2026
Trial IDNCT07431554 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–80 with confirmed or suspected past HAPE who live below 800 m and have not had recent exposure above 2,500 m within the prior three weeks are ideal candidates.

Probably not a fit

People with other diagnosed cardiopulmonary disease, pregnancy or lactation, permanent residence above 800 m, recent high-altitude exposure, or inability to complete study procedures are not eligible and are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with past HAPE will be exposed, in random order, to three simulated oxygen levels corresponding roughly to 490 m, 2,500 m and 4,000 m both at rest and during light cycling exercise using a controlled gas mixture. The trial uses a randomized, double-blind, cross-over design so each participant experiences all conditions without knowing which is being simulated. Right ventricular function will be measured noninvasively with speckle-tracking echocardiography, and investigators will also record heart rate, blood pressure, blood gases, tissue oxygenation and symptoms such as shortness of breath. The study is single-center and focuses on acute (short-term) physiologic responses rather than long-term outcomes.

Why it matters

Potential benefit: If successful, the results could help identify who with past HAPE is at risk for right-heart strain at altitude and inform safer guidance for mountain activities.

How similar studies have gone: Previous research has shown acute right-ventricular changes during simulated hypoxia and used speckle-tracking echocardiography, but applying these methods specifically to people with past HAPE is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Signed informed consent
* Diagnosed or suspicion of past HAPE
* 18-80 years (age group young: 18-39.99 years / age group older: 40-80 years)
* All sex and genders
* Living \<800m and without altitude exposure \> 2500 m and \> 24h within the last three weeks

Exclusion Criteria:

* \<18, \>80 years old
* Any other diagnosed cardiopulmonary condition
* Other clinically significant severe concomitant disease states (e.g. renal, hepatic dysfunction, etc.)
* Inability to follow the procedures of the study due to language problems, psychological neurological disorders or orthopaedic disorders
* Participants permanently living \>800m and altitude exposure \> 2500 m and \>24h within the last three weeks
* Pregnancy: Participants will be asked if pregnant or not, no screening for undetected pregnancy
* Lactating women
* Participation in other study with active treatment

Where it's running

  • Consultant Clinic of Pulmonology, University Hospital of Zurich
    Zurich, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.